位置:成果数据库 > 期刊 > 期刊详情页
肝纤维化抵抗对乙酰氨基酚诱导的致死性损伤及其机制
  • ISSN号:1007-3418
  • 期刊名称:《中华肝脏病杂志》
  • 时间:0
  • 分类:R971.1[医药卫生—药品;医药卫生—药学]
  • 作者机构:[1]首都医科大学附属北京佑安医院人工肝中心,100069, [2]首都医科大学附属北京佑安医院病理科,100069, [3]北京市肝病研究所
  • 相关基金:国家“十二五”科技重大专项基金(2012ZX10002004-006,2012ZX10004904-003-001,2013ZX10002002-006-001)I首都医科大学基础--临床合作项目(14JL72,14JL73);国家卫计委2014重点建设专科项目资助课题(WJWYA-2014-002,wJwYA-2014-004);北京市医院管理局临床医学发展专项经费资助(XM201308)北京市卫生系统高层次卫生技术人才项目(2011-3-083,2013-3-071)
中文摘要:

目的 证明四氯化碳(CCl4)诱导的肝纤维化能够保护小鼠抵抗致死性对乙酰氨基酚(APAP)攻击,并初步探讨其发挥保护作用的机制. 方法 建立CCl4诱导的肝纤维化小鼠模型,于纤维化6周时以致死剂量的APAP(1 g/kg)进行攻击,以同样处理的正常小鼠作为对照.即实验共分为4组:对照组、急性损伤组(APAP组)、肝纤维化组(Fib组)、肝纤维化+急性攻击组(Fib+APAP组),每组5只.根据攻击前后小鼠生存率、转氨酶水平及肝组织学的变化来评估正常和纤维化小鼠对致死性APAP损伤的耐受性.免疫组织化学法分析各组小鼠肝组织中高迁移率族蛋白1(HMGB1)的表达.组间差异的比较采用One-way ANOVA分析和Newman-Keuls检验. 结果 接受APAP攻击的纤维化小鼠的肝损害程度明显轻于同样处理的正常小鼠,表现为:(1) Fib+APAP组小鼠的生存率明显高于APAP组(80%对比0); (2) Fib+APAP组小鼠的sALT升高水平显著低于APAP组[(6437±1 913) U/L对比(12 456±3 441) U/L],P=0.022,攻击前后,正常小鼠的sALT水平升高了257.4倍,而纤维化小鼠则仅升高了12.2倍;(3) Fib+APAP组的肝组织学检查结果较APAP组明显改善.免疫组织化学分析结果表明,APAP组小鼠肝组织中HMGB1呈高表达,并且可见明显的HMGB1由胞核向胞质转位,而Fib+APAP组HMGB1的表达明显弱于APAP组,且胞质转位少见.结论 CCl4诱导的肝纤维化可能通过限制HMGB1的胞质转位及其所触发的损伤效应而保护小鼠抵抗致死性APAP的攻击.

英文摘要:

Objective To investigate the protective effects of hepatic fibrosis against a lethal dose ofacetaminophen (APAP) and its underlying mechanisms using a carbon tetrachloride (CCl4)-induced mouse model of fibrosis.Methods The experimental model of hepatic fibrosis was established by intraperitoneal injection of CC14 (in mineral oil),twice a week for 6 weeks; mice given a 6-week course of mineral oil injections served as normal controls.At the end of fibrosis induction,the expmimental (Fib group) and control (Norm group) mice were challenged with APAP (1 g/kg).Sera and liver tissues were harvested for analyses.To assess tolerance of the normal and fibrotic mice to the lethal dose of APAP,the survival rate,serum alanine aminotransferase (sALT) levels and hepatic histopathological changes were compared before and after the acute APAP challenge.HMGB 1 expression was analyzed by immunohistochemistry.One-way ANOVA test and Newman-Keuls test were used in statistical analysis.Results The fibrotic liver was tolerant to the lethal dose of APAP,as evidenced by:(1) significantly higher survival rate in the Fib±APAP group (80% vs.Norm+APAP group:0%); (2) markedly lower sALT levels in the Fib+APAP group (6 437±1 913 U/L vs.12 456± 3 441 U/L),P =0.022; (3) remarkably well-preserved liver architecture in the Fib+APAP group.Immunohistochemical analysis showed high HMGB1 expression and cytoplasmic translocation in the Norm+APAP group,which was absent in the Fib+APAP group.Conclusions CCl4-induced liver fibrosis protects mice against lethal dose of APAP,possibly by a mechanism involving inhibition of the cytoplasmic translocation of HMGB1.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华肝脏病杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中华医学会
  • 主编:
  • 地址:重庆市渝中区临江路74号
  • 邮编:400010
  • 邮箱:chnhepa@online.cq.cn
  • 电话:023-63706512
  • 国际标准刊号:ISSN:1007-3418
  • 国内统一刊号:ISSN:50-1113/R
  • 邮发代号:78-56
  • 获奖情况:
  • 中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),荷兰文摘与引文数据库,美国生物医学检索系统,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版)
  • 被引量:47128